Clinical trial

Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective…

NCT00135772 · National Institute on Drug Abuse (NIDA), NIH · Completed

Key facts

NCT number NCT00135772
Title Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2
Official title Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder
Lead sponsor National Institute on Drug Abuse (NIDA), NIH
Status Completed
Study type Observational
Conditions Schizophrenia and Disorders With Psychotic Features, Tobacco Use Disorder
Enrollment 100
Start date Oct 1, 2003
Primary completion Jul 1, 2004
Completion Jul 1, 2004
First posted Aug 26, 2005
Last update posted Jan 12, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies